Results 91 to 100 of about 4,434,840 (211)

Recommended Phase 2 Dose for Abemaciclib in Combination With Temozolomide in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results From Study JPCS Part B

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cyclin‐dependent kinase 4/6 (CDK4/6) pathway aberrations, including CDK4 or CCND1 amplification, CDKN2A/B loss, retinoblastoma (RB) dysregulation, and cyclin D overexpression, are relevant for pediatric cancers. Abemaciclib, a selective CDK4/6 inhibitor with preferential CDK4 activity and central nervous system (CNS) penetration ...
Alvaro Lassaletta   +10 more
wiley   +1 more source

Journal of Proton Therapy: Call for Papers

open access: yes, 2015
Journal of Proton Therapy (JPT) is an international open access, peer-reviewed journal, which publishes original research, technical reports, reviews, case reports, editorials, and other materials on proton therapy with focus on radiation oncology ...
Proton Therapy, Journal of
core  

American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients.

open access: yes
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to create a guideline focusing on non-Aspergillus invasive molds, which are uncommon
Shigle, T.L.   +10 more
core   +1 more source

Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With Venetoclax

open access: yesCase Reports in Hematology
Patients with multiple myeloma (MM) have an inherent risk for secondary myeloid malignancies. Innovative approaches to treatment are needed when these hematologic malignancies co-occur.
Allison O. Taylor   +4 more
doaj   +1 more source

Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation

open access: yesFrontiers in Immunology, 2018
Cytomegalovirus (CMV) remains a major cause of morbidity following allogeneic hematopoietic stem cell transplant. Natural killer cells expressing NKG2C have been shown to play a role in the immune surveillance of human CMV.
Kai Cao   +19 more
doaj   +1 more source

Immune Trait Polygenic Scores Among Survivors of Hodgkin Lymphoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Epidemiologic evidence links immune‐related conditions to Hodgkin lymphoma (HL), but the shared genetic architecture remains unclear. Using data from the St. Jude Survivorship Portal, pre‐computed polygenic risk scores (PRSs) for 12 allergy and immune‐related traits were compared between 794 survivors of HL and 3664 survivors of non ...
Ji Yun Tark   +3 more
wiley   +1 more source

Peptide-binding motifs define the functional architecture of human leukocyte antigens

open access: yesGenome Medicine
Background Peptide presentation by polymorphic human leukocyte antigens (HLA) is central to adaptive and innate immunity. HLA polymorphism gives rise to allele-specific peptide-binding motifs (PBM) that shape the immunopeptidomes presented across ...
Pietro Crivello   +5 more
doaj   +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng   +3 more
wiley   +1 more source

P1376: LENALIDOMIDE–BASED MAINTENANCE AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK MULTIPLE MYELOMA

open access: yesHemaSphere, 2022
O. Pasvolsky   +17 more
doaj   +1 more source

The Impact of Tenapanor on Body Composition and Blood Pressure in Peritoneal Dialysis Patients: A Pilot Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Instruction Tenapanor potentially affects fluid volume and blood pressure. This study explored its effects on these parameters in patients undergoing peritoneal dialysis (PD). Methods We conducted a single‐arm, prospective observational study that enrolled 10 patients on PD with hyperphosphatemia who were newly initiated on tenapanor.
Shun Yoshida   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy